When the treatment regimen was changed from prostaglandin analogs and β-blockers to travoprost 0.004%/timolol maleate 0.5% fixed combination eye drops, administration protocol adherence increased and IOP was preserved; however, adverse reactions appeared in about 16% of the cases.
No takes yet. Share an insight, caveat, or question.
Goldberg et al. (1990) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: